Led by Kimberly Martin, MD, the TrialNet team at Akron Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Akron Children's Hospital is regionally overseen by University of Pittsburgh. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Carol Huang, MD, Ph.D, the TrialNet team at Alberta Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Alberta Children's Hospital is regionally overseen by The Hospital for Sick Children. If you reach out to TrialNet, you may be contacted by staff from either institution

Led by Evan Los, MD, the TrialNet team at Ballad Health is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Ballad Health is regionally overseen by Vanderbilt Eskind Diabetes Clinic. If you reach out to TrialNet, you may be contacted by staff from either institution. 

The Barbara Davis Center is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Andrea Steck MD, the TrialNet team at the Barbara Davis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Mustafa Tosur MD., the TrialNet Baylor College of Medicine team at the Texas Children's Hospital is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Baylor College of Medicine is regionally overseen by University of Texas Southwestern. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Benaroya Research Institute (BRI) is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Carla Greenbaum, MD, the TrialNet team at BRI is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Children's Mercy Hospital is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Wayne Moore, MD, PhD the TrialNet team at Children's Mercy is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Led by Shideh Majidi, MD, the TrialNet team at Children's National Medical Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Childrens National Medical Center is regionally overseen by the University of Pittsburgh. If you reach out to TrialNet, you may be contacted by staff from either institution. 

Led by Roshanak Monzavi, MD, the TrialNet team at Childrens Hospital Los Angeles is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Note: As a TrialNet affiliate, Childrens Hospital Los Angeles is regionally overseen by University of California - San Francisco. If you reach out to TrialNet, you may be contacted by staff from either institution. 

CHOC Children's is one of eighteen type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Mark Daniels, MD, the TrialNet team at CHOC Children's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.